Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Jill Condello
Advertisement
Articles by Jill Condello
Advertisement
Latest Updated Articles
Access and Reimbursement for Adoptive T-Cell Transfer DrugsDecember 11th 2017
Advertisement
Advertisement
Trending on PharmExec
1
The Next Biopharma Revolution: Quantum Computing
2
How Medications like XOCOVA Prevent Illness After Exposure to COVID-19
3
Roundup: Astellas Licenses IL-12 Fusion Protein From Audax in Deal Worth Up to $1.34 Billion, EVERSANA Acquires Health Economics Firm Estima Scientific
4
Roundup: Teva Acquires BXCL501 for $57.5 Million Upfront, Rumi Therapeutics Enters Option Agreement for Fragile X PDE2 Inhibitor From Enthorin
5